Decibel Therapeutics, Inc. announced that it has expanded its leadership team with the addition of chief data sciences officer John Keilty. Decibel has also appointed three new members to its board of directors: Troyen A. Brennan, M.D., M.P.H., executive vice president and chief medical officer, CVS Health; Roger H. Brown, president, Berklee College of Music; and George A. Scangos, Ph.D., chief executive officer, Vir Biotechnologies, Inc. John Keilty joins Decibel from Third Rock Ventures where he served as the general manager of platform operations, responsible for the development and implementation of technology roadmaps for companies across the portfolio. Prior to this role, John was the vice president of information technology and informatics at Infinity Pharmaceuticals where he owned information systems, software development, computational science, biostatistics, clinical data management and clinical informatics. Dr. Troyen Brennan is executive vice president and chief medical officer of CVS Health. In this role, Troy oversees the development of CVS Health’s clinical and medical affairs and health care strategy, as well as the company’s CVS MinuteClinic and Accordant Health Care business. Roger Brown assumed the presidency of Berklee College of Music in 2004 and has created the world’s largest online music education system to attract students from 105 countries. In 2017, Dr. George Scangos assumed the position of chief executive officer of Vir Biotechnology, Inc. He served as chief executive officer of Biogen from 2010 and 2016 has more than 20 years of experience in the pharmaceutical and healthcare industries.